HopeStage
Back to all studies
CompletedNCT01057329

Monitoring medication levels and side effects in child and adolescent psychiatry

About this titleRead the official source — NCT01057329
Observational studyAges 10–19AustriaEating disorders
The study in practice

Understand this study

Who was this study for?

Listed age limits: 10 years to 19 years.

Listed locations
ViennaSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJanuary 2010
Recruitment status
Completed
Enrollment listed in the registry
200
Sponsor
Medical University of Vienna
Sponsor type
University
Study type
Observational
Intervention type
Drug
Locations
Austria
Age range
From 10 Years to 19 Years
Official registry ID
NCT01057329
Official title
Show the full official title

Therapeutic Drug Monitoring (TDM) in Child & Adolescent Psychiatry

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Vienna

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Medical University of Vienna, a university.

Did this study involve medication?

Yes. The study involved medication, including Atomoxetine, Duloxetine, Olanzapine and Aripiprazole.

Who was this study for?

Listed age limits: 10 years to 19 years.

Want to explore more studies?

Explore studies